ASLAN Pharmaceuticals Announces Plan To Implement ADS Ratio Change From 1 ADS Representing 25 Shares To 1 ADS Representing 200 Shares (1-For-8 ADS Split), Effective Date For The Ratio Change, July 3, 2024
Portfolio Pulse from Benzinga Newsdesk
ASLAN Pharmaceuticals (NASDAQ: ASLN) announced a change in the ratio of its American Depositary Shares (ADS) from 1 ADS representing 25 shares to 1 ADS representing 200 shares, effective July 3, 2024.
June 14, 2024 | 9:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
ASLAN Pharmaceuticals is changing its ADS ratio from 1 ADS representing 25 shares to 1 ADS representing 200 shares, effective July 3, 2024. This 1-for-8 ADS split could impact the stock's liquidity and price.
The change in ADS ratio is a significant equity action that could affect the stock's liquidity and price. However, the overall impact on the company's valuation remains neutral in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100